The use of subcutaneous immunoglobulin (SCIG 20%) and subcutaneous immunoglobulin enhanced with hyaluronidase (fSCIG) in Polish pediatric patients with primary immunodeficiencies - a retrospective review.
RETROSPECTIVE STUDY
BioStat® oversees the fluid course of the study and data analysis.
Please direct all questions to the Organizer's office.